Arcadia Biosciences, Inc. - Common Stock (RKDA)

Historical Holders from Q4 2017 to Q1 2023

Symbol
RKDA on Nasdaq
Type / Class
Equity / Common Stock
Shares outstanding
1,390,020
All holders as of 31 Mar 2023
Q1 2023
Total 13F shares, excl. options
0
Holdings value
$0
Number of holders
0
Number of sells
-26
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Arcadia Biosciences, Inc. - Common Stock (RKDA)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
SABBY MANAGEMENT, LLC 4.9% $17,028 68,111 SABBY MANAGEMENT, LLC 31 Dec 2024

Institutional Holders of Arcadia Biosciences, Inc. - Common Stock (RKDA)

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price Investors
2023 Q1 0 $0 -$639,500 0
2022 Q4 2,366,535 $639,500 -$254,174 $0.2710 26
2022 Q3 3,279,360 $1,729,000 +$775,233 $0.5279 20
2022 Q2 1,706,820 $1,707,136 -$245,035 $1.00 19
2022 Q1 1,918,328 $2,684,000 -$453,395 $1.40 23
2021 Q4 2,337,881 $2,428,000 -$2,445,760 $1.04 24
2021 Q3 3,161,441 $6,543,000 +$1,274,798 $2.07 18
2021 Q2 2,492,120 $7,400,000 +$4,101,343 $2.97 24
2021 Q1 1,150,714 $3,170,000 +$191,545 $2.75 22
2020 Q4 1,116,093 $2,823,000 +$624,930 $2.53 17
2020 Q3 869,117 $2,435,000 +$932,821 $2.80 18
2020 Q2 523,085 $1,969,000 +$371,528 $3.77 14
2020 Q1 427,264 $1,218,000 -$643,194 $2.86 11
2019 Q4 496,981 $2,722,000 -$790,872 $5.48 13
2019 Q3 662,670 $3,101,000 +$1,149,076 $4.68 17
2019 Q2 479,719 $1,471,000 +$709,694 $3.07 13
2019 Q1 192,623 $1,350,000 +$38,014 $7.01 10
2018 Q4 282,070 $894,000 -$561,407 $3.17 10
2018 Q3 438,889 $2,144,000 -$22,395 $4.88 12
2018 Q2 342,140 $2,822,000 -$4,604,714 $8.25 11
2018 Q1 395,430 $10,023,000 +$10,016,000 $24.01 11
2017 Q4 26,228 $7,000 +$7,000 $0.2669 1